GB1508517A - Method for preparing 17alpha-ester-21-halo pregnanes - Google Patents

Method for preparing 17alpha-ester-21-halo pregnanes

Info

Publication number
GB1508517A
GB1508517A GB8947/76A GB894776A GB1508517A GB 1508517 A GB1508517 A GB 1508517A GB 8947/76 A GB8947/76 A GB 8947/76A GB 894776 A GB894776 A GB 894776A GB 1508517 A GB1508517 A GB 1508517A
Authority
GB
United Kingdom
Prior art keywords
halo
ester
pregnanes
halide
acyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8947/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50038914A external-priority patent/JPS51125372A/ja
Priority claimed from JP50052085A external-priority patent/JPS51128954A/ja
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of GB1508517A publication Critical patent/GB1508517A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB8947/76A 1975-03-31 1976-03-05 Method for preparing 17alpha-ester-21-halo pregnanes Expired GB1508517A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50038914A JPS51125372A (en) 1975-03-31 1975-03-31 Aprocess for preparing pregnane steroid-17-ester-21-halides
JP50052085A JPS51128954A (en) 1975-05-01 1975-05-01 Process for preparing 17-ester-21-halides of pregnate type s teroids

Publications (1)

Publication Number Publication Date
GB1508517A true GB1508517A (en) 1978-04-26

Family

ID=26378215

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8947/76A Expired GB1508517A (en) 1975-03-31 1976-03-05 Method for preparing 17alpha-ester-21-halo pregnanes

Country Status (14)

Country Link
US (1) US4113680A (US07223432-20070529-C00017.png)
CA (1) CA1044225A (US07223432-20070529-C00017.png)
CH (1) CH609709A5 (US07223432-20070529-C00017.png)
DE (1) DE2613875A1 (US07223432-20070529-C00017.png)
DK (1) DK141171B (US07223432-20070529-C00017.png)
ES (1) ES446411A1 (US07223432-20070529-C00017.png)
FR (1) FR2306214A1 (US07223432-20070529-C00017.png)
GB (1) GB1508517A (US07223432-20070529-C00017.png)
HU (1) HU174850B (US07223432-20070529-C00017.png)
IN (1) IN142583B (US07223432-20070529-C00017.png)
NL (1) NL7603249A (US07223432-20070529-C00017.png)
PT (1) PT64885B (US07223432-20070529-C00017.png)
SE (1) SE403380B (US07223432-20070529-C00017.png)
YU (1) YU54476A (US07223432-20070529-C00017.png)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2742982C2 (de) * 1977-09-21 1985-12-12 Schering AG, 1000 Berlin und 4709 Bergkamen 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4361558A (en) * 1980-04-29 1982-11-30 Ciba-Geigy Corporation Halogenated steroids
US4440689A (en) * 1981-07-22 1984-04-03 Mitsubishi Chemical Industries, Limited Acyloxysteroids and process for producing same
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
DE3915951C1 (US07223432-20070529-C00017.png) * 1989-05-12 1990-09-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
DK1305329T4 (da) * 2000-08-05 2015-06-15 Glaxo Group Ltd 6alpha, 9alpha-difluor-17alpha-(2-furanylcarboxyl)oxy-11beta-hydroxy-16alpha-methyl-3-oxo-androst-1,4-dien-17-carbothiosyre-S-fluormethylester som et antiinflammatorisk middel
PL366937A1 (en) * 2001-04-30 2005-02-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
AU2002356759A1 (en) * 2001-12-01 2003-06-17 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
AT501376B1 (de) * 2005-01-17 2010-11-15 Pregenzer Bruno Glucokortikoid-hältiges arzneimittel
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN109608511B (zh) * 2019-01-24 2021-05-04 上海新华联制药有限公司 泼尼松龙醋酸戊酸酯的化学合成工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE373332C (sv) * 1972-02-25 1977-07-25 Centralsug Ab Anordning for utvinning av fibermaterial ur blandat gods
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
CH609709A5 (US07223432-20070529-C00017.png) 1979-03-15
YU54476A (en) 1982-05-31
US4113680A (en) 1978-09-12
IN142583B (US07223432-20070529-C00017.png) 1977-07-30
FR2306214B1 (US07223432-20070529-C00017.png) 1981-04-30
ES446411A1 (es) 1979-02-01
DK141171C (US07223432-20070529-C00017.png) 1980-07-07
SE403380B (sv) 1978-08-14
NL7603249A (nl) 1976-10-04
DK144076A (US07223432-20070529-C00017.png) 1976-10-01
SE7603791L (sv) 1976-10-01
PT64885A (en) 1976-04-01
CA1044225A (en) 1978-12-12
FR2306214A1 (fr) 1976-10-29
PT64885B (en) 1977-11-17
DE2613875A1 (de) 1976-10-14
DK141171B (da) 1980-01-28
HU174850B (hu) 1980-03-28

Similar Documents

Publication Publication Date Title
GB1508517A (en) Method for preparing 17alpha-ester-21-halo pregnanes
GB1531050A (en) Preparation of corticoids
DE3474025D1 (en) Carboxylic acid esters of steroids
NO304987B1 (no) Kortikosteroid-17-alkylkarbonat-21-[O]-karboksylsyre- og karbonsyreestere, legemidler inneholdende disse, samt anvendelse av forbindelsene
UA26860C2 (uk) Спосіб одержаhhя (22r,s)-16 альфа,17 альфа-бутилідеhдіокси-11 бета, 21-дигідроксипрегhа-1,4-дієh-3,20-діоhу
AU2999177A (en) Improved Ointment Containing Esters of Betamethasone
IE38312L (en) 17ó-esters of 17ó,21-dihydroxy-20-oxo-steroids.
ES461872A1 (es) Procedimiento para la obtencion de esteres de acido ciclo- propancarboxilico sustituidos por vinilo.
GB1464328A (en) Preparation of esters of aminocarboxylic acids
GB1497265A (en) Pregnan-21-oic acid derivatives and the use and manufacture of pregnan-21-oic acid derivatives
NO832040L (no) Fremgangsmaate for fremstilling av propionsyre fra fermentert myse
IE36529B1 (en) Esters of betamethasone and its 9alpha-chloro analogue
GB1500396A (en) Diesters
IE44866L (en) Halogenated-16ó-methylpregnanes
JPS54119690A (en) Jumper wire
GB1355663A (en) 19-nortestosterone 17- -p-substituted phenoxy-acetates
IE42468L (en) 13-ethynyl- and 13-(2 halovinyl)-steroids
ES2002923A6 (es) Procedimiento para preparar 4-hidroxi-2-oxo-pirrolidin-1-il-acetamida.
IE44886L (en) Quinoline carboxylic acid esters
TAKEDA et al. BILE ACIDS AND STEROIDS II. STUDIES ON HOG BILE ACIDS (PART 2). PROGESTERONE FROM HYODESOXYCHOLIC ACID
ES357387A1 (es) Procedimiento para la preparacion de nuevos 16,17-(metilenosustituidos)-esteroides.
GB1180176A (en) Novel Steroid 21-Esters, their Preparation, and Compositions containing them
GB1273955A (en) Dexamethasone-17-valerate and processes for preparing it
AU1830876A (en) Esters of prostaglandin b 2 (pgd2)
GB1504133A (en) 2-bromo-6beta-fluoro-pregnane compounds

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee